Opendata, web and dolomites


Cyclometallated ruthenium complexes for photo-activated chemotherapy

Total Cost €


EC-Contrib. €






 CylcoRu4PACT project word cloud

Explore the words cloud of the CylcoRu4PACT project. It provides you a very rough idea of what is the project "CylcoRu4PACT" about.

keeping    chemotherapy    tumour    irradiation    penetrates    chemotherapeutic    metal    quenches    ruthenium    tumours    sterically    usually    patient    containing    tissues    lines    hard    treatment    cytotoxicity    fails    energy    complexes    place    photodynamic    visible    minimizing    photochemical    released    concentration    photochemotherapeutic    wavelengths    cyclometallated    red    shift    occurring    sensitive    cancer    consist    wavelength    light    polypyridyl    phototherapy    maximizing    efficient    ligand    human    concentrations    synthesize    introduce    vitro    photosubstitution    cyclometallation    excited    carbon    compound    alternative    optimally    curing    limit    synthesized    window    biological    cell    groups    too    photoreactivity    hindering    hypoxic    compounds    locally    overcome    absorption    modifies    prodrugs    oxygen    toxicity    efficacy    clinic    measured    anticancer    dark    stand    bond    recover    determined    model    therapy    treatments    grounds    reactions   

Project "CylcoRu4PACT" data sheet

The following table provides information about the project.


Organization address
address: RAPENBURG 70
city: LEIDEN
postcode: 2311 EZ

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website
 Total cost 165˙598 €
 EC max contribution 165˙598 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-04-01   to  2020-03-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITEIT LEIDEN NL (LEIDEN) coordinator 165˙598.00


 Project objective

Chemotherapy is efficient in curing cancer, but most treatments are very hard to stand for the patient, and side effects limit treatment efficacy. Phototherapy is a promising alternative, where the toxicity of a light-sensitive chemotherapeutic compound is locally released upon visible light irradiation of the compound-containing tumour. Photodynamic therapy is already available in the clinic for oxygen-rich tumours; however, it fails when the oxygen concentration at the place of irradiation is too low. In this project I propose to synthesize new ruthenium-based photochemotherapeutic compounds containing cyclometallated ligand, and to test them in an in vitro model of hypoxic cancer. The presence of a carbon-metal bond is known to shift the light absorption properties of ruthenium polypyridyl complexes towards the photodynamic window, a wavelength range where light penetrates optimally into biological tissues. However, cyclometallation usually quenches the ligand photosubstitution properties of ruthenium compounds because it strongly modifies the energy of their excited states. In this project, I will introduce sterically hindering groups on the cyclometallated ligand to recover photoreactivity of the complexes while keeping light absorption at high wavelengths. The challenges of this project consist on the one hand in achieving efficient ligand photosubstitution reactions with cyclometallated ruthenium compounds, and on the other hand in minimizing the cytotoxicity in the dark while maximizing cytotoxicity after red light irradiation at low oxygen concentrations. The ruthenium prodrugs will be synthesized, their photochemical properties will be measured, and their cytotoxicity against human cancer cell lines will be determined in an in vitro model of hypoxic cancer. This project will set new grounds in the treatment of hypoxic tumours and propose a new way to overcome side effects occurring in traditional anticancer chemotherapy.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CYLCORU4PACT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CYLCORU4PACT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

PopulistFP (2019)

The Populist Politics of Foreign Policy

Read More  

GenEl (2020)

General readout electronics for cross-sectoral application in European research infrastructure

Read More  


Identification and characterization of enteric nervous system stem cells

Read More